BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31955497)

  • 21. Is COVID-19 infection more severe in kidney transplant recipients?
    Caillard S; Chavarot N; Francois H; Matignon M; Greze C; Kamar N; Gatault P; Thaunat O; Legris T; Frimat L; Westeel PF; Goutaudier V; Jdidou M; Snanoudj R; Colosio C; Sicard A; Bertrand D; Mousson C; Bamoulid J; Masset C; Thierry A; Couzi L; Chemouny JM; Duveau A; Moal V; Blancho G; Grimbert P; Durrbach A; Moulin B; Anglicheau D; Ruch Y; Kaeuffer C; Benotmane I; Solis M; LeMeur Y; Hazzan M; Danion F;
    Am J Transplant; 2021 Mar; 21(3):1295-1303. PubMed ID: 33259686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer survival in kidney transplant recipients in Ireland.
    Murray SL; O'Leary E; De Bhailís ÁM; Deady S; Daly FE; O'Kelly P; Williams Y; O'Neill JP; Sexton DJ; Conlon PJ
    Nephrol Dial Transplant; 2020 Oct; 35(10):1802-1810. PubMed ID: 32638007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous melanoma is related to immune suppression in kidney transplant recipients.
    Vajdic CM; van Leeuwen MT; Webster AC; McCredie MR; Stewart JH; Chapman JR; Amin J; McDonald SP; Grulich AE
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2297-303. PubMed ID: 19622722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.
    Vicari AR; Spuldaro F; Sandes-Freitas TV; Cristelli MP; Requião-Moura LR; Reusing JO; Pierrotti LC; Oliveira ML; Girão CM; Gadonski G; Kroth LV; Deboni LM; Ferreira GF; Tedesco-Silva H; Esmeraldo R; David-Neto E; Saitovitch D; Keitel E; Garcia VD; Pacheco-Silva A; Medina-Pestana JO; Manfro RC
    Transpl Infect Dis; 2016 Oct; 18(5):730-740. PubMed ID: 27503081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer.
    Chamie K; Ghosh PM; Koppie TM; Romero V; Troppmann C; deVere White RW
    Am J Transplant; 2008 Dec; 8(12):2668-73. PubMed ID: 18853950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
    Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer characteristics and outcome in renal transplant recipients: results from a contemporary single center study.
    Pettenati C; Jannot AS; Hurel S; Verkarre V; Kreis H; Housset M; Legendre C; Méjean A; Timsit MO
    Clin Transplant; 2016 Aug; 30(8):964-71. PubMed ID: 27251769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.
    van Leeuwen MT; Webster AC; McCredie MR; Stewart JH; McDonald SP; Amin J; Kaldor JM; Chapman JR; Vajdic CM; Grulich AE
    BMJ; 2010 Feb; 340():c570. PubMed ID: 20150194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study.
    Cazzaniga W; Garmo H; Robinson D; Holmberg L; Bill-Axelson A; Stattin P
    BJU Int; 2019 Mar; 123(3):421-428. PubMed ID: 30253031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
    Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
    Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden.
    Bratt O; Berglund A; Adolfsson J; Johansson JE; Törnblom M; Stattin P;
    Scand J Urol Nephrol; 2010 Dec; 44(6):384-90. PubMed ID: 20624113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients.
    Imlay H; Whitaker K; Fisher CE; Limaye AP
    Transpl Infect Dis; 2018 Aug; 20(4):e12928. PubMed ID: 29809315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of prostate cancer in renal-transplant recipients.
    Binsaleh S
    Int Urol Nephrol; 2012 Feb; 44(1):149-55. PubMed ID: 21614508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Belatacept Compared With Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study.
    Cohen JB; Eddinger KC; Forde KA; Abt PL; Sawinski D
    Transplantation; 2017 Oct; 101(10):2582-2589. PubMed ID: 27941427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of May 2003.
    Gruessner AC; Sutherland DE
    Clin Transpl; 2003; ():21-51. PubMed ID: 15387096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate Cancer in Renal Transplant Recipients: Diagnosis and Treatment.
    Carvalho JA; Nunes P; Dinis PJ; Antunes H; Parada B; Marconi L; Moreira P; Roseiro A; Bastos C; Rolo F; Dias V; Figueiredo A
    Transplant Proc; 2017 May; 49(4):809-812. PubMed ID: 28457400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
    di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
    Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.